metaclazepam has been researched along with Anxiety Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marano, P; Nicoletti, F; Patti, F | 1 |
| Blaschke, D; Hippius, H; Laakmann, G; Schewe, S | 1 |
2 trial(s) available for metaclazepam and Anxiety Disorders
| Article | Year |
|---|---|
Controlled study on the anxiolytic activity of a newly-developed benzodiazepine, metaclazepam.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Bromazepam; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Random Allocation | 1988 |
Double-blind randomized trial of the benzodiazepine derivative metaclazepam as compared with placebo treatment of outpatients with anxiety syndromes.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Phobic Disorders; Psychological Tests; Random Allocation; Somatoform Disorders | 1988 |